Healthcare

Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals, collaborate on Genetic Medicines Project with support from UKRI Innovate UK and Canadian R&D Funding

EDINBURGH, Scotland, TORONTO and EDMONTON, AB, Jan. 6, 2026, 08:00 GMT-05

CHROMATIN-BIOSCIENCE

Read full article →

BLA for subcutaneous formulation of Leqembi® accepted in China

STOCKHOLM, Jan. 6, 2026, 06:22 GMT-05

BIOARCTIC-Eisai-BLA

Read full article →

LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington's Disease

CAMBRIDGE, England, Jan. 6, 2026, 03:30 GMT-05

LoQus23-Therapeutics

Read full article →

Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation

COPENHAGEN, Denmark, Jan. 6, 2026, 03:30 GMT-05

Acesion-Pharma

Read full article →

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

LONDON, Jan. 6, 2026, 03:19 GMT-05

Clarivate-Plc

Read full article →

Spectrumedics Announces CE Mark Approval For Its Coronary Intravascular Lithotripsy System

SINGAPORE, Jan. 6, 2026, 03:00 GMT-05

Spectrumedics-CE

Read full article →

Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD

SHANGHAI, Jan. 6, 2026, 02:10 GMT-05

Ark-Biopharmaceutical

Read full article →

Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight

LAS VEGAS, Jan. 5, 2026, 17:31 GMT-05

DELVEINSIGHT-BUSINESS

Read full article →

BoomerangFX Expands UK and EMEA Operations With New UK Office and Senior Appointments as demand for AI Clinic Co-Pilot AUVIA™ Drives Record Growth in Healthcare

LONDON, Jan. 5, 2026, 14:51 GMT-05

BoomerangFX-expansion

Read full article →

Clear Aligner Material Market Valued at USD 3.5 Billion in 2024, Set to Reach USD 7.2 Billion by 2033 at a 9.5% CAGR (2026-2033) - Market Research Intellect

LEWES, Del., Jan. 5, 2026, 10:50 GMT-05

Market-Research-Intel

Read full article →

Vagus Nerve Stimulation Market is expected to generate a revenue of USD 23.73 Billion by 2031, Globally, at 10.50% CAGR: Verified Market Research®

LEWES, Del., Jan. 5, 2026, 10:45 GMT-05

VERIFIED-MARKET

Read full article →

Cell Culture Vessels Market worth $8.03 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 5, 2026, 10:30 GMT-05

MarketsandMarkets

Read full article →

Pharmaceutical Isolator Market Size to Reach USD 509 Million by 2031 | CAGR 2.4% - Valuates Reports

BANGALORE, India, Jan. 5, 2026, 10:01 GMT-05

VALUATES-REPORTS

Read full article →

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

LONDON, Jan. 5, 2026, 05:00 GMT-05

ACCORD-HEALTHCARE-VP

Read full article →

Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

COPENHAGEN, Denmark, Jan. 5, 2026, 04:47 GMT-05

Curasight

Read full article →

Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries

SINGAPORE, Jan. 5, 2026, 04:30 GMT-05

HyphensPharma

Read full article →

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

HONG KONG, Jan. 5, 2026, 03:15 GMT-05

GenEditBio

Read full article →

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025, 20:14 GMT-05

QimingVenturePartners

Read full article →

Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence

AUSTIN, Texas and TOKYO, Dec. 29, 2025, 06:40 GMT-05

DATAM-INTELLIGENCE

Read full article →

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

STOCKHOLM, Dec. 29, 2025, 02:49 GMT-05

DIAMYD-Clinical-Trial

Read full article →